US Patent Issued to Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical Group on Feb. 3 for "Anti-BCMA antibody, antigen-binding fragment thereof and medical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,190, issued on Feb. 3, was assigned to Shanghai Hansoh Biomedical Co. Ltd. (Shanghai) and Jiangsu Hansoh Pharmaceutical Group Co. Ltd. (Lianyungang, China).

"Anti-BCMA antibody, antigen-binding fragment thereof and medical use thereof" was invented by Haiqing Hua (Shanghai) and Rudi Bao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-BCMA antibody, an antigen-binding fragment thereof, and a medical use thereof. Further provided are a chimeric antibody and a humanized antibody containing a CDR region of the anti-BCMA antibody, a pharmaceutical composition containing the anti-BCMA antibody or the antigen-binding fragment t...